Role of lymphocyte-to-monocyte ratio as a predictive marker for diabetic coronary artery disease: A cross-sectional study

BACKGROUND The lymphocyte to monocyte ratio(LMR)is considered a marker of systemic inflammation in cardiovascular disease and acts as predictor of mortality in coronary artery disease.AIM To investigate the predictive role of LMR in diabetic coronary artery disease patients.METHODS This cross-sectional study was conducted at tertiary care super-specialty hospital at New Delhi,India.A total of 200 angiography-proven coronary artery disease(CAD)patients were enrolled and grouped into two categories:Group I[CAD patients with type 2 diabetes mellitus(T2DM)and glycated hemoglobin(HbA1c)levels≥6.5%],and Group II(CAD patients without T2DM and HbA1c levels<6.5%).Serum lipoproteins,HbA1c,and complete blood count of enrolled patients were analyzed using fully automatic analyzers.RESULTS The logistic regression analysis showed an odds ratio of 1.48(95%CI:1.28-1.72,P<0.05)for diabetic coronary artery disease patients(Group I)in unadjusted model.After adjusting for age,gender,diet,smoking,and hypertension history,the odds ratio increased to 1.49(95%CI:1.29-1.74,P<0.01)in close association with LMR.Further adjustment for high cholesterol and triglycerides yielded the same odds ratio of 1.49(95%CI:1.27-1.75,P<0.01).Receiver operating characteristic curve analysis revealed 74%sensitivity,64%specificity,and 0.74 area under the curve(95%CI:0.67-0.80,P<0.001),suggesting moderate predictive accuracy for diabetic CAD patients.CONCLUSION LMR showed positive association with diabetic coronary artery disease,with moderate predictive accuracy.These findings have implications for improving CAD management in diabetics,necessitating further research and targeted interventions.

Analysis of the Peripheral Blood Helper T-Cell 17- Cell Level and Monocyte/Lymphocyte Ratio for Colorectal Cancer Prognosis Prediction

Objective: To investigate the value of peripheral blood helper T cell 17 cell level and monocyte/lymphocyte ratio to predict the prognosis of colorectal cancer patients. Methods: 74 colorectal cancer patients who attended Hospital 960 from January 2021 to January 2022 were retrospectively analyzed. Clinical data of the patients were collected, including gender, age, and histologic type. Immunohistochemical indexes such as Th17 cell level and monocyte/ lymphocyte ratio in the peripheral blood of patients were also collected. The prognosis of patients after treatment, as well as peripheral blood Th17 and MLR levels, were observed and analyzed. Results: After follow-up after treatment, in the final 74 patients, the prognosis was good in 32 patients, accounting for 43.24%, and the prognosis was bad in 42 patients, accounting for 56.76%. There were no significant differences between the average age and tumor diameters of the good prognosis and poor prognosis groups (P > 0.05). However, the TNM staging, intervention taken, differentiation degree, presence of distant metastasis, presence of lymph node metastasis, Th17 level, and MLR level are significantly different between the two groups (P < 0.05). Conclusion: Peripheral blood Th17 and MLR have predictive value for the prognosis of colorectal cancer patients, and high levels of peripheral blood Th17 and MLR imply poor prognosis. The detection of peripheral blood Th17 and MLR levels is simple and convenient and can be used as indicators to provide a reference for the prognostic assessment of colorectal cancer patients.

Monocyte-to-lymphocyte ratio as a prognostic factor in peripheral whole blood samples of colorectal cancer patients

BACKGROUND Colorectal cancer is the third most common malignancy worldwide.Therefore,it is critically important to identify new useful markers that can be easily obtained in routine practice.Inflammation is a crucial issue in the pathogenesis and development of cancer.AIM To evaluate the prognostic value of absolute monocyte count,monocyte to lymphocyte ratio(MLR),the combination of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio(NLR-PLR),and combined platelet and neutrophilto-lymphocyte ratio(PLT-NLR)in peripheral blood samples of patients with colorectal cancer undergoing surgery.METHODS We conducted a retrospective study of 160 patients with colorectal cancer who underwent surgery,and 42 healthy controls.The status of absolute monocyte count,MLR,NLR-PLR and PLT-NLR was calculated on the basis of blood samples obtained before and after surgery.Haematologic factors were examined in correlation with the type of tumour growth,tumour size,histological type,percentage of mucinous component,grade of malignancy,Tumour-Node-Metastasis stage,venous,lymphatic and perineural invasion of cancer cells,status of lymph node invasion and the presence of cancer cell deposits.The Kaplan-Meier method and the long-rank test were used to compare survival curves.To determine independent prognostic factors,univariate and multivariate Cox proportional hazards regression models were applied.RESULTS The PLT-NLR status was correlated with tumour size and the presence of perineural invasion(P=0.015;P=-0.174,P=0.037).Moreover,high NLR-PLR and PLR-NLR ratios in the blood samples obtained after surgery were positively associated with histological type of cancer and percentage of the mucinous component(NLR-PLR:P=0.002;P=0.009;PLR-NLR status:P=0.002;P=0.007).The analysis of 5-year disease-free survival showed that the MLR of whole blood obtained after surgery[HR=2.903,95%CI:(1.368-6.158),P=0.005]and the status of lymph node metastasis[HR=0.813,95%CI:(0.653-1.013),P=0.050]were independent prognostic factors in colorectal cancer patients.CONCLUSION The postoperative MLR in whole blood samples can be used as an independent prognostic factor in patients diagnosed with colorectal cancer.

Systemic immune inflammation index, ratio of lymphocytes to monocytes, lactate dehydrogenase and prognosis of diffuse large Bcell lymphoma patients

BACKGROUND In malignant tumors,inflammation plays a vital role in the development,invasion,and metastasis of cancer cells.Diffuse large B-cell lymphoma(DLBCL),the most common malignant proliferative disease of the lymphatic system,is commonly associated with inflammation.The international prognostic index(IPI),which includes age,lactate dehydrogenase(LDH),number of extranodal lesions,Ann Arbor score,and Eastern Cooperative Oncology Group(ECOG)score,can evaluate the prognosis of DLBCL.However,its use in accurately identifying highrisk patients and guiding treatment is poor.Therefore,it is important to find novel immune markers in predicting the prognosis of DLBCL patients.AIM To determine the association between the systemic immune inflammation index(SII),ratio of lymphocytes to monocytes(LMR),ratio of LMR to LDH(LMR/LDH),and prognosis of patients with DLBCL.METHODS A total of 68 patients diagnosed with DLBCL,treated in our hospital between January 2016 and January 2020,were included.χ2 test,Pearson’s R correlation,Kaplan Meier curves,and Cox proportional risk regression analysis were used.The differences in the SII,LMR,and LMR/LDH among patients with different clinicopathological features were analyzed.The differences in progression-free survival time among patients with different SII,LMR,and LMR/LDH expressions and influencing factors affecting the prognosis of DLBCL patients,were also analyzed.RESULTS The LMR and LMR/LDH in patients with Ann Arbor stage III–IV,ECOG score≥2,and SII,IPI score 2–5 were significantly higher than those of patients with Ann Arbor stage I-II and ECOG score<2(P<0.05).Patients with high SII,LMR,and LMR/LDH had progression-free survival times of 34 mo(95%CI:32.52–38.50),35 mo(95%CI:33.42–36.58)and 35 mo(95%CI:33.49–36.51),respectively,which were significantly lower than those with low SII,LMR,and LMR/LDH(P<0.05);the SII,LMR,and LMR/LDH were positively correlated(P<0.05).Cox proportional risk regression analysis showed that the SII,LMR,and LMR/LDH were influencing factors for the prognosis of DLBCL patients(hazard ratio=1.143,1.665,and 1.704,respectively;P<0.05).CONCLUSION The SII,LMR,and LMR/LDH are related to the clinicopathological features of DLCBL,and they also influence the prognosis of patients with the disease.

The combined prognostic value of pretreatment neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio in stage IE/IIE extranodal natural killer/T-cell lymphoma

Objective This study aimed to explore the combined prognostic value of pretreatment neutrophil-tolymphocyte ratio(NLR), lymphocyte-to-monocyte ratio(LMR), and platelet-to-lymphocyte ratio(PLR) in newly diagnosed IE/IIE extranodal natural killer/T-cell lymphoma(ENKTL) treated with a P-Gemox regimen combined with radiotherapy or radiotherapy alone.Methods A total of 132 patients from 2009 to 2017 at the Sichuan Cancer Hospital were enrolled in the study. The cutoff values of NLR, LMR, and PLR using overall survival(OS) rate as an endpoint were obtained by the receiver operating curve. Results The cutoff value of NLR was 3.5. Patients with high NLR had significantly shorter progressionfree survival(PFS)(P < 0.001) and OS(P < 0.001) than those with low NLR. Similarly, the cutoff value of LMR was 3.0. The high LMR group had significantly longer PFS(P=0.001) and OS(P < 0.001) than the low LMR group. Similarly, the cutoff value of PLR was 191.7. The high PLR group was significantly associated with poor PFS(P < 0.001) and OS(P < 0.001) than the low PLR group. Furthermore, combining NLR, LMR, and PLR to build a new model to stratify patients into low-, intermediate-, intermediate-high-, and high-risk groups, there were also significant differences in PFS(P < 0.001) and OS(P < 0.001). The univariate analysis showed that presenting B symptoms, stage IIE, local tumor invasion, Eastern Cooperative Oncology Group score ≥ 2, elevated lactate dehydrogenase level, elevated NLR, decreased LMR, and elevated PLR were significantly associated with poor survival. The multivariate analysis demonstrated that PLR was an independent prognostic factor for both PFS(hazard ratio [HR]= 2.073, 95% confidence interval [CI]= 1.080–3.981, P = 0.028) and OS(HR = 2.127, 95% CI = 1.102–4.107, P = 0.025).Conclusion Elevated pretreatment PLR was a novel simple predictor of poor survival in patients with stage IE/IIE ENKTL. Combining NLR, LMR, and PLR could provide additional stratification.

The prognostic value of lymphocyte-to-monocyte ratio in retinopathy of prematurity

AIM： To evaluate the associations between development of retinopathy of prematurity（ROP） and serum lymphocyteto-monocyte ratio（LMR）, neutrophil-to-lymphocyte ratio（NLR）, and platelet-to-lymphocyte ratio（PLR）. METHODS： A retrospective cohort study was performed, involving infants who were screened for ROP from January 2015 to December 2015. Preterm newborns of ≤32 gestational weeks with ROP were enrolled as the observation group, and non-ROP infants were enrolled as the control group, whose complete blood cell were measured within the first 24 h of life. The levels of NLR, LMR and PLR were determined in all groups. The data obtained were analyzed using univariate and multivariate logistic regression analysis.RESULTS： In this study, 40 cases of ROP were enrolled and 40 cases of non-ROP as controls. The LMR levels were significantly higher（P〈0.001） in ROP group（3.96±1.16） compared to non-ROP group（2.85±0.79）. The NLR levels were significantly lower（P=0.035） in ROP group {median [interquartile range（IQR）], 0.88（0.67-1.46）} compared to non-ROP group [median（IQR）, 1.20（0.85-1.89）]. The median PLR values were 61.99（IQR, 50.23-75.98） in ROP group and 69.24（IQR, 55.52-88.12） in non-ROP group（P=0.104）. Logistic regression analysis suggested that LMR was an independent risk factor for ROP（OR： 0.275; 95% CI： 0.134-0.564; P=0.001）. CONCLUSION： The findings demonstrate that higher LMR is independently and significantly associated with the development of ROP, and the LMR may be invoked as a predictive tool for identifying risk for ROP.

Evaluation of the neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte lymphocyte ratio for diagnosis of testicular torsion

Objective:To explore the value of complete blood count(CBC),including neutrophil-lymphocyte ratio(NLR),platelet-lymphocyte ratio(PLR),and monocyte lymphocyte ratio(MLR)in diagnosis of testicular torsion(TT)and differential diagnosis from epididymo-orchitis.Methods:The study was conducted at the Antalya Training and Research Hospital Emergency Department in Turkey with acute scrotal pain patients from January 1st,2016 to January 1st,2018.The patients were categorized into 3 groups:the TT group who underwent an operation for TT(n=70),the epididymo-orchitis group who received epididymo-orchitis treatment(n=120),and the healthy control group(n=100).NLR,PLR,and MLR of the three groups were analysed and compared.The optimum cut-off values of NLR,MLR,and PLR were analyzed.Results:Mean NLR and MLR values were significantly higher in the epididymo-orchitis group and the TT group compared to the control group(P<0.001).Receiver operating characteristic analysis revealed a sensitivity of 77.1%and a specificity of 80%for NLR(77.1)and a sensitivity of 68.2%and a specificity of 78%for PLR(124.80).Moreover,when MLR was used to differentiate the two treatment groups,the optimal cut-off value had a sensitivity of 67.1%and a specificity of 75%(AUC:0.677-0.826,P<0.001).Conclusions:NLR,PLR,and MLR might be associated with the diagnosis of TT.These parameters provide a useful and economical method to help diagnose TT in the emergency department.

The Lower Peripheral Blood Lymphocyte to Monocyte Ratio Following Completion of First Line Chemotherapy Is a Risk Factor for Predicting Relapse in Patients with Diffuse Large B-Cell Lymphoma

Background and objective: During routine follow up, there is no specific predictor to ascertain relapse after standard first line chemotherapy in diffuse large cell lymphoma. Therefore, this study was designed to assess the prognostic significance of the ratio between absolute lymphocyte and monocyte counts (LMR) in the peripheral blood to verify relapse in diffuse large B cell lymphoma. Patients and methods: A total of 139 patients with newly diagnosed diffuse large B cell lymphoma (DLBCL) were evaluated and treated with CHOP or R-CHOP between the years 2009 and 2016. Three months following completion of first line therapy, Lymphocyte/monocyte ratio (LMR) was calculated from the routine automated complete blood cell count (CBC) attained a plateau after the bone marrow recovery after first line chemotherapy. The absolute lymphocyte count/absolute monocyte count ratio (LMR) was calculated by dividing the ALC by the AMC. Results: ROC curve analysis of 139 patients established 2.8 as cutoff point of LMR for relapse with AUC of 0.97 (95% CI 0.93 - 0.99, P ≤ 0.001). Cox regression analysis was performed to identify factors predicting relapse. In univariate regression analysis, ALC (95% CI 0.003 - 0.03, p ≤ 0.001), AMC (95% CI 15.4 - 128.8, p ≤ 0.001), LMR (95% CI 0.001 - 0.01, p ≤ 0.001), and LDH (95% CI 0.1 - 0.5, p ≤ 0.001) following completion of therapy are significant factors for relapse. Other significant factors for relapse are Ann Arbor stage (95% CI 1.1 - 6.9, P = 0.03), extranodal sites (95% CI 1.2 - 6.1, P = 0.01), age (95% CI 1.3 - 6.5, P = 0.01) and treatment of CHOP protocol (95% CI 0.05 - 0.6, P = 0.007). In a multivariate analysis LMR following completion of therapy was predictive for relapse (95% CI 0.001 - 0.2, P = 0.005). ALC was also significant in multivariate analysis (95% CI 0.01 - 0.8, P = 0.03). LDH following completion of therapy (95% CI 0.2 - 14.9, P = 0.5), AMC following completion of therapy (95% CI 0.3 - 43.1, P = 0.3), age (95% CI 0.9 - 205.4, P = 0.06), extra-nodal sites (95% CI 0.04 - 9.8, P = 0.8), Ann Arbor stage (95% CI 0.3 - 28.7, P = 0.3), and Treatment of CHOP protocol (95% CI 0.01 - 2.4, P = 0.2) were not statistically significant. Conclusion: This study observed that LMR assessed after first line chemotherapy during routine follow up is an independent predictor of relapse and clinical outcome in DLBCL patients. LMR at follow up can be used a simple inexpensive biomarker to alert clinicians for relapse during follow up after standard first line chemotherapy in DLBCL patients.

Absolute Lymphocyte/Monocyte Ratio at Diagnosis and Interim Positron-Emission Tomography Predict Survival in Classical Hodgkin Lymphoma

Interim Positron-Emission Tomography (int-PET) and the peripheral blood absolute lymphocyte/monocyte ratio at di- agnosis (ALC/AMC-DX) have been shown to be predictors for progression-free survival (PFS) and time to progression (TTP) in classical Hodgkin lymphoma (cHL). Therefore, we studied if the combination of ALC/AMC-DX and the (int-PET) can further stratified PFS and TTP in cHL patients. Patients were required to be diagnosed, treated, and followed with int-PET at Mayo Clinic, Rochester, Minnesota. From 2000 until 2008, 111 cHL patients qualified for the study. The median follow-up was 2.8 years (range: 0.3 - 10.4 years). Patients with a negative int-PET (N = 98) pre- sented with a higher ALC/AMC-DX (median of 2.32, range: 0.26 - 37.5) compared with patients with a positive int-PET (N = 13) (median of 0.9, range: 0.29 - 3.10), p 1.1. Group 1 experienced superior PFS and TTP in comparison with the other groups. In conclusion, the combination of ALC/AMC-DX and the int-PET provides a simple model to assess clinical outcomes in cHL.

外周血NLR、NMR、LMR表达与帕金森病的相关性研究

目的探讨外周血中性粒细胞与淋巴细胞之比(NLR)、中性粒细胞与单核细胞之比(NMR)、淋巴细胞与单核细胞之比(LMR)表达水平与帕金森病(PD)的相关性。方法选取224例原发性PD患者为病历组,230例健康人为对照组,检测其外周血中NLR、NMR、LMR水平。①比较PD组和对照组间的NLR、NMR、LMR水平是否存在差异;②比较PD组按照不同因素分层后NLR、NMR、LMR水平是否存在差异;③分析PD组NLR、NMR、LMR的水平是否与临床特征之间存在相关性。结果①在总体样本中,PD组和对照组间NLR、NMR、LMR水平的比较差异均无统计学意义(均P>0.05)。按照性别、年龄分层,各亚组PD患者与其相对应正常对照组间NLR、NMR、LMR水平差异均无统计学意义(均P>0.05);②PD组按不同因素分层后:A.发病年龄>65岁PD组NLR水平(2.84±1.22)高于发病年龄≤65岁PD组(2.46±1.16),差异有统计学意义(P=0.018);B.女性PD组NMR水平(12.08±3.71)高于男性PD组(10.91±3.27),差异有统计学意义(P=0.013)女性PD组LMR水平(5.12±1.72)高于男性PD组(4.43±1.62),差异有统计学意义(P=0.002);C.病程>4年PD组和病程≤4年PD组间、早中晚三期PD组间、三种运动亚型(震颤为主型、姿势不稳/步态障碍型、混合型)PD组间、合并痴呆PD组和未合并痴呆PD组间的NLR、NMR、LMR水平比较差异均无统计学意义(均P>0.05);(3)PD组NLR水平与发病年龄存在正相关(r=0.223,P=0.001),LMR水平与发病年龄存在负相关(r=-0.202,P=0.002);PD组NLR、NMR、LMR水平与病程、H-Y分级、UPDRS-Ⅲ评分、NPI评分不存在相关性(均P>0.05)。结论外周血NLR、NMR、LMR水平在PD患者和正常健康人群间无差异,此三项指标均非导致PD患病的危险因素。NLR在发病年龄>65岁PD患者中的表达水平较发病年龄≤65岁PD患者高;NMR、LMR在女性PD患者中的表达水平较男性PD患者高。PD患者NLR表达水平与发病年龄呈正相关,而LMR表达水平与发病年龄呈负相关。

蛛网膜下腔出血患者外周血NLR、LMR、PLR和SII值变化的临床意义

目的 分析动脉瘤性蛛网膜下腔出血(aSAH)对血液学参数的影响及其与患者临床状态和短期预后的关系。方法 分析2019年3月至2022年5月于四川省科学城医院神经外科治疗的62例颅内动脉瘤(IA)破裂急性期患者和55例正常对照组。采用流式细胞术分析两组患者外周血中白细胞(WBC)与淋巴细胞(LC)计数的变化,计算中性粒细胞/淋巴细胞比(NLR)、淋巴细胞/单核细胞比(LMR)、血小板/淋巴细胞比(PLR)和全身免疫-炎症指数(SII),并分析血液学参数与患者临床状况和短期预后的关系。结果 与正常对照组相比,IA破裂组WBC、中性粒细胞(Ns)计数、NLR以及SII均明显升高,而LC计数和LMR降低。此外相比于临床状态恢复良好的患者,临床状态较差的患者LC计数明显降低,而NLR、PLR和SII值明显升高。格拉斯哥昏迷评分法(GCS)评分较低的患者CD3+、CD4-、CD8-细胞比例减少。此外,LC计数降低和PLR升高与较差的短期预后相关。结论 IA破裂后会导致全身免疫和炎症反应,LC计数、NLR、PLR和SII值可以作为临床状态及预后的标志物。

NLR、LMR、PLR在自身免疫性肝炎患者中的表达及意义

目的探讨自身免疫性肝炎(AIH)患者中炎性指标表达及意义。方法选取2019年1月—2022年1月龙岩市第二医院收治的91例AIH患者作为本次研究对象,作为AIH组,另外选取同期健康体检患者90例为对照组,比较两组患者肝脏生化和免疫指标及中性粒细胞-淋巴细胞比值(NLR)、血小板-淋巴细胞比值(PLR)、淋巴细胞-单核细胞比值(LMR)三项血细胞指标。结果AIH组患者的谷丙转氨酶(ALT)、谷草转氨酶(AST)、总胆红素(TBIL)、免疫球蛋白G(IgG)等肝脏生化指标均高于对照组(均P<0.05);AIH组NLR、PLR指标水平均高于对照组,LMR水平低于对照组(均P<0.05);经过二元logistic回归分析,NLR、PLR、LMR均是AIH的独立危险因素(均P<0.05)。根据绘制ROC曲线显示,NLR、PLR、LMR的AUC值分别为0.941、0.996、0.863,PLR诊断的价值高于NLR和LMR(P<0.05)。结论肝脏生化和免疫指标与AIH发生有影响,NLR、LMR、PLR是AIH的独立危险因素,在诊断AIH具有应用价值。

LMR联合hs-CRP对急性胰腺炎患者并发急性肾损伤的诊断价值

目的探讨淋巴细胞计数与单核细胞计数比值(LMR)联合超敏C反应蛋白(hs-CRP)对急性胰腺炎(AP)患者并发急性肾损伤(AKI)的诊断价值。方法选取2019年10月至2023年11月该院收治的226例AP患者作为研究对象,根据住院期间是否并发AKI分为AKI组(62例)和非AKI组(164例)。采用血液分析仪检测淋巴细胞计数和单核细胞计数,计算LMR;采用特定蛋白免疫分析仪检测hs-CRP水平。收集所有研究对象入院时肝功能、血脂等生化指标。采用Pearson相关分析AP患者LMR与hs-CRP水平的相关性。采用受试者工作特征(ROC)曲线分析LMR联合hs-CRP对AP患者并发AKI的诊断价值。采用多因素Logistic回归分析AP患者并发AKI的影响因素。结果AKI组低密度脂蛋白胆固醇、血肌酐、丙氨酸转氨酶、天冬氨酸转氨酶水平均高于非AKI组,差异均有统计学意义(P<0.05)。AKI组LMR低于非AKI组,hs-CRP水平高于非AKI组,差异均有统计学意义(P<0.05)。Pearson相关分析结果显示,AP患者LMR与hs-CRP水平呈负相关(r=-0.645,P<0.001)。LMR联合hs-CRP检测对诊断AP患者并发AKI的曲线下面积(AUC)高于LMR、hs-CRP单独检测的AUC(Z=2.531,P=0.011;Z=3.244,P=0.001)。多因素Logistic回归分析结果显示,血肌酐、LMR、hs-CRP是AP患者并发AKI的影响因素(P<0.05)。结论AP并发AKI患者LMR水平明显降低,hs-CRP水平明显升高,二者联合检测对AP患者并发AKI有一定诊断价值。

ⅡA/ⅡB期睾丸精原细胞瘤术后患者放疗前后肿瘤标志物、LMR动态变化及其对近期疗效的影响

目的分析ⅡA/ⅡB期睾丸精原细胞瘤术后患者放疗前后肿瘤标志物、淋巴细胞/单核细胞比值(LMR)动态变化及其与放疗效果的关系。方法回顾性分析山西省肿瘤医院2012年7月至2020年7月收治的70例ⅡA/ⅡB期睾丸精原细胞瘤术后患者的临床资料,根据放疗近期疗效情况将患者分为有效组(n=16)和无效组(n=54)。记录并整理患者基线资料、放疗前后肿瘤标志物水平及LMR值,分析肿瘤标志物、LMR与放疗近期疗效的关系。结果肿瘤直径>40 mm、睾丸血管浸润是影响ⅡA/ⅡB期睾丸精原细胞瘤术后患者放疗近期效果的危险因素(P<0.05)。有效组放疗后血清乳酸脱氢酶(LDH)水平低于放疗前,LMR值高于放疗前(P<0.05);无效组放疗前、后血清LDH水平高于有效组,LMR值低于有效组(P<0.05)。两组放疗前、后血清甲胎蛋白(AFP)、人绒毛膜促性腺激素(hCG)水平比较及组内比较,差异均无统计学意义(P>0.05)。放疗前、后血清LDH水平与肿瘤直径、睾丸血管浸润均呈正相关(r>0,P<0.05);放疗前、后LMR值与肿瘤直径、睾丸血管浸润均呈负相关(r<0,P<0.05)。放疗前血清LDH水平、LMR值及联合预测放疗无效的曲线下面积均>0.7,联合预测的价值更高。结论睾丸精原细胞瘤患者术后血清LDH水平、LMR值与放疗近期疗效密切相关。

血清CAR LMR T淋巴细胞亚群与多发性骨髓瘤患者预后的相关性分析

目的:探讨血清C反应蛋白与白蛋白比值(CAR)、淋巴细胞/单核细胞比值(LMR)、T淋巴细胞亚群与多发性骨髓瘤(MM)患者预后的相关性。方法:选取2020年1月至2022年1月诊治的105例多发性骨髓瘤患者作为研究对象,设立为观察组,同期选取75例健康体检者设立为对照组。根据MM患者治疗后随访2年是否出现复发或死亡分为预后不良组(n=34)和预后良好组(n=71),对比血清CAR、LMR、T淋巴细胞亚群(CD3^(+)、CD4^(+)、CD8^(+)、CD4^(+)/CD8^(+))。采用Logistic回归分析CAR、LMR、CD3^(+)、CD4^(+)、CD8^(+)、CD4^(+)/CD8^(+)对MM患者预后的影响。采用ROC曲线模型分析CAR、LMR、CD3^(+)、CD4^(+)、CD8^(+)、CD4^(+)/CD8^(+)、T淋巴细胞亚群综合参数预测MM患者预后的AUC值、敏感度和特异度。结果:观察组的CAR、CD8^(+)高于对照组,而LMR、CD3^(+)、CD4^(+)、CD4^(+)/CD8^(+)低于对照组(P<0.05)。预后不良组的CAR、CD8^(+)高于预后良好组,而LMR、CD3^(+)、CD4^(+)、CD4^(+)/CD8^(+)低于预后良好组(P<0.05)。二元Logistic回归分析显示,CAR、CD8^(+)升高和LMR、CD3^(+)、CD4^(+)、CD4^(+)/CD8^(+)下降会对MM患者预后产生影响(P<0.05)。ROC曲线分析显示,CAR、LMR、CD3^(+)、CD4^(+)、CD8^(+)、CD4^(+)/CD8^(+)、T淋巴细胞亚群综合参数预测MM患者预后的AUC值分别为(0.637、0.792、0.726、0.767、0.669、0.750、0.853,P<0.05)。结论:血清CAR、LMR、T淋巴细胞亚群在MM患者中呈异常表达趋势,检测其变化有利于为评估MM患者的预后提供重要参考。

PNI、LMR、MELD对肝移植术后早期肺部感染的预测价值

目的探讨原位肝移植患者术后早期发生肺部感染的相关危险因素,并构建肝移植术后早期肺部感染的预测模型。方法回顾性分析首次行原位肝移植的269例患者的临床资料,根据术后30 d内是否发生肺部感染分为感染组(97例)和未感染组(172例),收集患者术前一般资料、术前实验室检查结果、术中和术后资料。采用多因素Logistic回归分析肺部感染的危险因素,基于多因素分析结果构建预测模型并评估模型预测效能。结果2组经单因素和多因素Logistic回归分析,术前预后营养指数(PNI)≤41.70(OR=1.972,95%CI:1.047~3.714,P=0.036)、淋巴细胞计数与单核细胞计数比值(LMR)≤1.52(OR=2.020,95%CI:1.102~3.705,P=0.023)、终末期肝病模型(MELD)>10.72(OR=1.985,95%CI:1.103~3.573,P=0.022)、手术时间>448 min(OR=2.676,95%CI:1.515~4.727,P=0.001)、重症监护病房(ICU)住院时间>4.0 d(OR=2.623,95%CI:1.335~5.154,P=0.005)是肝移植术后早期肺部感染的独立危险因素。基于多因素分析结果构建的预测模型的受试者工作特征曲线下面积为0.768,敏感度为80.41%,特异度为60.47%。结论基于PNI、LMR、MELD、手术时间、ICU住院时间构建的预测模型可有效预测肝移植术后早期肺部感染的发生。

Prognostic value of neutrophil/lymphocyte,platelet/lymphocyte,lymphocyte/monocyte ratios and Glasgow prognostic score in osteosarcoma:A meta-analysis

BACKGROUND Some studies investigated the prognostic role of several blood biomarkers,including the neutrophil/lymphocyte ratio(NLR),platelet/lymphocyte ratio(PLR),lymphocyte/monocyte ratio(LMR)and Glasgow prognostic score(GPS),in osteosarcoma,but their results were inconsistent with each other.AIM To identify the prognostic value of NLR,PLR,LMR and GPS in osteosarcoma patients through reviewing relevant studies.METHODS The PubMed,EMBASE,Web of Science and CNKI databases were searched up to October 2,2021.The primary and second outcomes were overall survival(OS)and disease-free survival(DFS),respectively.The hazard ratios(HRs)with 95%confidence intervals(CIs)were combined to assess the association between these indicators and prognosis of osteosarcoma patients.RESULTS A total of 13 studies involving 2087 patients were eventually included.The pooled results demonstrated that higher NLR and GPS were significantly associated with poorer OS(HR=1.88,95%CI:1.38-2.55,P<0.001;HR=2.19,95%CI:1.64-2.94,P<0.001)and DFS(HR=1.67,95%CI:1.37-2.04,P<0.001;HR=2.50,95%CI:1.39-4.48,P<0.001).However,no significant relationship of PLR and LMR and OS(P=0.085;P=0.338)and DFS(P=0.396;P=0.124)was observed.CONCLUSION Higher NLR and GPS were related with worse prognosis and might serve as novel prognostic indicators for osteosarcoma patients.

LMR与老年原发性高血压患者焦虑的关系研究

目的 探究淋巴细胞计数与单核细胞计数比值(LMR)与老年原发性高血压(EH)患者焦虑之间的关系。方法 收集2020年7月至2021年12月在该院心血管内科住院治疗的年龄≥60岁197例EH患者入院时的基本资料、实验室检查指标。以汉密尔顿焦虑量表(HAMA)评分≥14分为临界值,将患者分为焦虑组与无焦虑组,比较两组患者基本资料与入院时LMR等指标差异。采用二元Logistic回归分析老年EH患者发生焦虑的影响因素。采用受试者工作特征(ROC)曲线分析LMR对老年EH患者发生焦虑的预测价值。结果 两组患者在饮酒史、吸烟史、LMR方面比较,差异有统计学意义(P<0.05)。二元Logistic回归分析结果显示,LMR(OR=1.742,95%CI:1.414~2.146,P<0.01)是原发性老年高血压患者发生焦虑的独立危险因素。ROC曲线分析结果显示,LMR预测老年EH患者发生焦虑的曲线下面积(AUC)为0.803(95%CI:0.740~0.866,P<0.001),最佳截断值为4.52,此时的灵敏度和特异度分别是0.71、0.84。结论 LMR水平升高是老年EH患者发生焦虑的独立危险因素,LMR对于老年EH患者发生焦虑具有较好的预测价值。

外周血淋巴细胞、LMR、IL-6对脓毒血症预后的预测价值

目的 探讨脓毒血症外周血淋巴细胞、淋巴细胞/单核细胞(LMR)、白细胞介素-6(IL-6)水平及三者对脓毒血症预后的预测价值。方法 选取2020年1月至2022年12月安徽省宿州市立医院儿童感染科收治的120例脓毒血症患儿临床资料,按病情分为轻症组(76例)、重症组(44例)。比较两组外周血淋巴细胞、LMR、IL-6水平;按10天转归情况将脓毒血症患者分为预后良好组(79例)和预后不良组(41例),比较两组上述血清指标、血常规[白细胞计数(WBC)、C反应蛋白(CRP)、降钙素原(PCT)、肿瘤坏死因子(TNF-α)]水平、急性生理及慢性健康状况Ⅱ(APACHEⅡ)和儿童序贯器官衰竭(p-SOFA)评分,并分析影响脓毒血症预后的相关因素及外周血淋巴细胞、LMR、IL-6水平对脓毒血症预后的预测价值。结果 轻症组外周血淋巴细胞、LMR水平高于重症组(t=7.033,4.828,P<0.05),IL-6低于重症组,差异均有统计学意义(t=6.880,P<0.05);预后良好组外周血淋巴细胞、LMR均高于预后不良组(t=6.915,5.932,P<0.05),APACHEⅡ、p-SOFA评分及IL-6、CRP、PCT、TNF-α水平低于预后不良组,差异均有统计学意义(5.552,7.893,6.778,17.540,14.868,12.296,P<0.05);外周血淋巴细胞、LMR、IL-6、CRP、PCT、TNF-α及APACHEⅡ和p-SOFA均是引起预后不良的独立影响因素(P<0.05);外周血淋巴细胞、LMR、IL-6对脓毒血症预后的联合预测效能高于单一检测(AUC=0.957,P<0.05)。结论 外周血淋巴细胞、LMR、IL-6在脓毒血症患儿中表达异常且均为其预后不良影响因素,三者联合预测对脓毒血症预后具有重要的预测价值。

急性冠脉综合征患者血浆LncRNA NEAT1、LMR水平变化及其临床意义

目的探讨血浆长链非编码RNA核内富集转录物1(LncRNA NEAT1)、淋巴细胞/单核细胞比值(LMR)与急性冠脉综合征(ACS)的相关性。方法选取2021年1月至2022年1月因胸闷胸痛等胸前区不适症状在娄底市中心医院心血管内科住院行冠状动脉造影术检查的194例患者作为研究对象。其中,冠状动脉造影检查阴性(冠状动脉造影检查显示冠状动脉正常)共50例,纳入对照组;其余144例冠状动脉造影检查阳性的患者(即ACS患者)根据诊断标准分为不稳定型心绞痛(UA)组(n=64)和急性心肌梗死(AMI)组(n=80)。用实时定量PCR检测各组血浆中LncRNA NEAT1的表达水平;检测并收集血常规淋巴细胞计数(LC)和单核细胞计数(MC)并计算出LMR水平。采用Spearman分析LncRNA NEAT1、外周血LMR、Gensini积分和肌钙蛋白I(TnI)的相关性;通过ROC曲线评估血浆LncRNA NEAT1、LMR对ACS的诊断效能。结果三组患者的吸烟史比较,差异有统计学意义(P<0.05),其中AMI组的有吸烟史率高于对照组,差异有统计学意义(P<0.017);AMI组的肌酸激酶同工酶(CK-MB)、TnI水平、Gensini积分高于对照组及UA组,差异有统计学意义(P<0.05)。AMI组的LncRNA NEAT1表达水平[1.85(1.45,2.31)]高于对照组[0.80(0.35,1.03)]、UA组[1.26(0.69,1.38)],UA组的LncRNA NEAT1表达水平高于对照组,差异有统计学意义(P<0.05)。AMI组的LMR水平(3.59±1.42)低于对照组(4.97±1.50)、UA组(4.63±1.45),差异有统计学意义(P<0.05)。相关性分析结果显示,LncRNA NEAT1与TnI呈正相关(r=0.684,P<0.001),LMR与TnI呈负相关(r=-0.317,P<0.05);LncRNA NEAT1与LMR呈负相关(r=-0.297,P<0.05);LncRNA NEAT1与Gensini积分呈正相关(r=0.654,P<0.001),LMR与Gensini积分呈负相关(r=-0.393,P<0.001)。ROC分析结果显示,血浆LncRNA NEAT1诊断ACS的AUC为0.855(95%CI:0.773~0.936,P<0.001),敏感度和特异度分别为76.4%和88.0%;LMR诊断ACS的AUC为0.684(95%CI:0.561~0.807,P<0.001),敏感度和特异度分别为84.7%和48.0%。结论血浆LncRNA NEAT1表达水平、LMR均与ACS及冠状动脉病变严重程度有关,可能可以作为潜在生物标志物辅助诊断ACS,并判断冠状动脉的病变严重程度。